"南光" 五號注射液

Pajjiż: Tajwan

Lingwa: Ċiniż

Sors: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Ingredjent attiv:

SODIUM CHLORIDE;;POTASSIUM ACETATE;;SODIUM ACETATE ANHYDROUS;;MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O);;POTASSIUM PHOSPHATE MONOBASIC(EQ TO POTASSIUM BIPHOSPHATE)(EQ TO POTASSIUM DIHYDROGEN PHOSPHATE);;DEXTROSE MONOHYDRATE

Disponibbli minn:

南光化學製藥股份有限公司 臺南市新化區全興里中山路1001號、1001-1號 (69275313)

Kodiċi ATC:

B05BB02

Għamla farmaċewtika:

注射劑

Kompożizzjoni:

POTASSIUM ACETATE (4008000100) MG; SODIUM ACETATE ANHYDROUS (4008000650) MG; MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O) (4012001550) MG; SODIUM CHLORIDE (4012002100) MG; DEXTROSE MONOHYDRATE (4020000570) MG; POTASSIUM PHOSPHATE MONOBASIC(EQ TO POTASSIUM BIPHOSPHATE)(EQ TO POTASSIUM DIHYDROGEN PHOSPHATE) (5612001910) MG

Unitajiet fil-pakkett:

瓶裝;;袋裝

Klassi:

製　劑

Tip ta 'preskrizzjoni:

限由醫師使用

Manifatturat minn:

南光化學製藥股份有限公司 台南市新化區全興里中山路１００１號 TW

Żona terapewtika:

electrolytes with carbohydrates

Indikazzjonijiet terapewtiċi:

手術前後及未能進食之病人之水份、電解質、熱能補充或維持液

Sommarju tal-prodott:

有效日期: 2028/12/23; 英文品名: NAKO NO.5 INJECTION "N.K."

Data ta 'l-awtorizzazzjoni:

1986-12-23